Stockscreener 앱 받기
7.70
3.51%
-0.28
시간 외 거래:
7.70
전일 마감가:
$7.98
열려 있는:
$8.01
하루 거래량:
15,894
Relative Volume:
0.12
시가총액:
$4.23M
수익:
-
순이익/손실:
$-17.06M
주가수익비율:
-0.1089
EPS:
-70.7173
순현금흐름:
$-14.18M
1주 성능:
-12.70%
1개월 성능:
-24.61%
6개월 성능:
-86.51%
1년 성능:
-95.59%
1일 변동 폭
$7.70
$8.2373
1주일 범위
$7.50
$9.0794
52주 변동 폭
$7.50
$221.94
Cns Pharmaceuticals Inc Stock (CNSP) Company Profile
명칭
Cns Pharmaceuticals Inc
전화
1-800-946-9185
주소
2100 WEST LOOP SOUTH, HOUSTON
CNSP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNSP
Cns Pharmaceuticals Inc
|
7.70 | 4.23M | 0 | -17.06M | -14.18M | -70.72 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Cns Pharmaceuticals Inc Stock (CNSP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-12-28 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2020-08-24 | 개시 | Ladenburg Thalmann | Buy |
Cns Pharmaceuticals Inc 주식(CNSP)의 최신 뉴스
Should I hold or sell CNS Pharmaceuticals Inc. stock in 2025Pre Market Forecasts That Work - jammulinksnews.com
What is the dividend policy of CNS Pharmaceuticals Inc. stockFinancial News Outlook For 2025 - jammulinksnews.com
Is CNS Pharmaceuticals Inc. stock overvalued or undervaluedMarket Forecast Signals For Fast Growth - jammulinksnews.com
CNS Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SaySwing Setup With Technical Confirmation Explained - metal.it
How does CNS Pharmaceuticals Inc. compare to its industry peersBeginner Investor Watchlist For 2025 - jammulinksnews.com
What makes CNS Pharmaceuticals Inc. stock price move sharplyTrade Insight With Community Collaboration Supported - metal.it
Published on: 2025-07-28 14:09:47 - metal.it
Will CNS Pharmaceuticals Inc. outperform the market Free Buy Low Sell High Stock Watch - Newser
Is it the right time to buy CNS Pharmaceuticals Inc. stockHigh-yield investments - jammulinksnews.com
What makes CNS Pharmaceuticals Inc. stock price move sharply 2-Day Signal Watch with Forecast Outcome - metal.it
Why is CNS Pharmaceuticals Inc. stock attracting strong analyst attentionCapitalize on trading strategies that deliver - jammulinksnews.com
How strong is CNS Pharmaceuticals Inc. company’s balance sheetExplosive earnings growth - jammulinksnews.com
Does CNS Pharmaceuticals Inc. stock perform well during market downturnsUnprecedented market success - jammulinksnews.com
Published on: 2025-07-27 20:34:14 - jammulinksnews.com
CNS Pharmaceuticals Inc. Stock Analysis and ForecastFree Market Dynamics Reports - PrintWeekIndia
What drives CNS Pharmaceuticals Inc. stock priceFree Stock Movement Tracking - Autocar Professional
What analysts say about CNS Pharmaceuticals Inc. stockFree Consultation - Autocar Professional
Is CNS Pharmaceuticals Inc. a good long term investmentSkyrocketing returns - jammulinksnews.com
Why CNS Pharmaceuticals Inc. stock attracts strong analyst attentionPrecision Entry Strategy - beatles.ru
CNS Pharmaceuticals Announces Reverse Stock Split - TipRanks
CNS Pharmaceuticals to Participate in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference - 富途牛牛
CNS Pharmaceuticals (NASDAQ: CNSP) CEO Featured In Virtual Investor Summer Spotlight Conference - Barchart.com
CNS Pharmaceuticals CEO Shares Brain Cancer Treatment Vision at Investor Conference | CNSP Stock News - Stock Titan
CNS Pharmaceuticals CEO Shares Vision at Virtual Investor Conference - citybuzz -
CNS Pharmaceuticals To Carry Out 1-for-12 Reverse Stock Split On July 22nd, 2025 - 富途牛牛
CNS Pharmaceuticals Implements 1-for-12 Reverse Stock Split to Consolidate Shares and Improve Market Position - AInvest
Published on: 2025-07-19 01:04:34 - jammulinksnews.com
CNS Pharmaceuticals (NASDAQ: CNSP) Announces 1-for-12 Reverse Stock Split Effective July 22 - Barchart.com
CNS Pharmaceuticals announces 1-for-12 reverse stock split By Investing.com - Investing.com Nigeria
Cns Pharmaceuticals Inc (CNSP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
0.15%
자본화:
|
볼륨(24시간):